If you liked this article you might like

Biogen Resolves Multiple Sclerosis Drug Dispute
Forward Pharma Shares Jump on Biogen License Agreement
Biotech Premarket Movers: SGMO, IPXL, PTLA
Bioverativ Makes Splash in Trading Debut, Gaining 18% on Day One